SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing significant downward pressure as investors rotate out of the stock due to concerns regarding AI capital expenditure and high-profile leadership changes. Community sentiment is currently polarized, with many retail traders expressing frustration over the stock's persistent underperformance relative to the broader market, while others view the current valuation as a contrarian long-term buying opportunity.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing intense volatility and heavy selling pressure as the community debates the impact of potential federal legislation aimed at regulating sports-based prediction markets. Investors remain deeply divided, with bears pointing to persistent insider selling and competitive threats from newer platforms, while bulls speculate that regulatory crackdowns on rivals could ultimately strengthen the company's market position.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors debate the impact of AI infrastructure demand and potential supply chain headwinds against its technical resilience and growth roadmap. The community is actively discussing the stock's stability relative to broader market volatility, with varied sentiment regarding whether current price levels represent an accumulation opportunity or an overextended valuation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing heightened investor interest and volatility as the market awaits imminent Phase 1/2 clinical data for its siRNA pipeline, which investors hope will validate a new platform for treating rare muscle diseases and drive a recovery beyond the company's existing DMD franchise. Community discussion is sharply divided between those positioning for a potential short squeeze fueled by significant short interest and those debating the long-term impact of regulatory headwinds and competition on the company's valuation.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is seeing significant upside momentum as retail investors flock to the stock as a proxy play for the highly anticipated SpaceX IPO, while community sentiment remains divided between those chasing the hype and those concerned about the fund trading at a premium to its net asset value. Active discussions are heavily centered on the fund's top-tier tech exposure, including SpaceX, Anthropic, and OpenAI, with many traders drawing comparisons to recent price action in similar thematic funds.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund ($VCX) is experiencing a parabolic, sentiment-driven rally fueled by extreme retail FOMO and its concentrated exposure to private tech giants like Anthropic, OpenAI, and SpaceX. Investors are actively debating whether the current price, which trades at a massive premium to the fund's NAV, is a justified "scarcity premium" during a lock-up period or a classic bubble that will eventually face a severe correction.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently experiencing high volatility and intense community debate surrounding its latest quarterly results, with investors weighing solid revenue growth and upbeat guidance against concerns over high valuations and broader semiconductor sector weakness. While the community remains deeply polarized, the active discussion centers on the company's long-term potential as a critical player in AI-driven data center infrastructure versus short-term skepticism regarding its ability to sustain current performance levels.

ORCASM is a filthy little memecoin that knows exactly what you came for. It launched on Orca's Wavebreak but was born to make waves—wet, loud, and unforgettable. This isn’t your ordinary meme. ORCASM builds up the tension slow, goes deep, and leaves you gasping for more. It’s raw, unfiltered trencher energy dripping with shameless satisfaction. No promises. No roadmaps. Just pure, orcasmic pleasure.

Orcasm

Orcasm is capturing significant trader attention as a speculative meme asset, with the community actively debating whether it marks a thematic shift from animal-based tokens to marine-themed projects. While supporters highlight its low market capitalization and potential for volatility, critics warn of high risk and potential manipulation, fueling polarized discussions among those looking for rapid, short-term gains.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is currently facing significant backlash from its user community following widespread reports of platform outages, login failures, and restricted access to trading specific tickers. Traders are actively expressing frustration over these technical malfunctions and perceived platform instability, fueling a broader discussion about reliability compared to alternative brokerages like Robinhood or Interactive Brokers.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is experiencing significant volatility driven by the surprise resignation of its CEO and a strategic management shift that installs the company's co-founders as co-CEOs. While some investors interpret the leadership transition as a sign of underlying instability, the community remains deeply divided, with many bulls viewing the move as a bullish long-term catalyst that reinstalls visionary leadership and maintains the brand's premium growth trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS PSA: Ceo has stated there have been interested Pharma&#39;s, and they &#39;will disclose to the public once they have something concrete&quot;. 
- 8K accelerating options for CFo/GC for Change of Control 
- elimination of Direct commercialization team, in lieu of pursuing partnerships, and beyond. 
- Poison Pill  
- no Rsu&#39;s for the CEO 
- No HR activity at all, with Phase 3 Results imminently due, to suggest commercializing, actually the opposite, a HR member left. 
- Phase 2 Trial Data w $MRK $BMY and $ABBV that is better than SOC for PR/ROC and AML-MR...

6,700% ROI this quarter

Gopirates1869

Tony M

Herda Christian

Slippin Jimmy RETURNS

Jeremy Dworkin

Margaret (Peggy) Murphy

Mustafizur Rahman

Thor

Walt

CMSP

$SLS Honestly I do strongly believe this.

They probably have been offered a buyout already, but for less than 10 billion. Sterg is a Greek he’s gonna be stubborn he knows what SLS is worth. 

Now that TERN has been bought out it will help us in negotiations… If a drug that’s not even in Phase 3 can allow for a $6 billion dollar buyout, what do you think a completed Phase 3 + a promising drug in Phase 2 would bring us??

$10 Billy starts to sound cheap when you think of it like this…

StockTwits for iOS

SELLAS Life Sciences Group Inc

$ABBV $BMY $MRK $SLS Sellas Dr. Angelos Stergiou and BOD will file 8K only when a written deal is accepted. 
Sellas GPS Paradigm shifting results will be historic for a curative WT1 platform, that can be used to treat 20+ other WT1 cancers using the recent FDA bayesian inference rules + National Priority Voucher (CNPV) pilot program. My long brothers and sisters The &quot;Bidding War&quot; for Sellas isn&#39;t just about a high price-it&#39;s about a strategic lockout. In the
2026 M&amp;A landscape, a “Stalking Horse&quot; bid (an initial, public offer intended to set the floor) from a company like Pfizer could trigger a cascade that forces Merck or BMS into their &quot;Max Bid&quot; territory to avoid losing the WT1 platform forever. GPS with unlimited dosing maintenance schedule is literally a perpetual money making machine.
Finally, You all are holding an asset GPS that solves the single biggest problem for the world&#39;s largest pharmaceutical companies unlimited dosing schedule. ✌️🙏❤️‍🩹

StockTwits Web

Merck & Co Inc

Bristol-Myers Squibb Co.

Abbvie Inc

 PSA: Ceo has stated there have been interested Pharma's, and they 'will disclose to the public once they have something concrete". 
- 8K accelerating options for CFo/GC for Change of Control 
- elimination of Direct commercialization team, in lieu of pursuing partnerships, and beyond. 
- Poison Pill  
- no Rsu's for the CEO 
- No HR activity at all, with Phase 3 Results imminently due, to suggest commercializing, actually the opposite, a HR member left. 
- Phase 2 Trial Data w 

 that is better than SOC for PR/ROC and AML-MR...